Trials / Completed
CompletedNCT00525096
Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
A Multicenter Randomized Phase III, Double-blind Study Comparing Efficacy of the Association of Exemestane and Celecoxib Versus Exemestane and Placebo in Menopausal Patients With Metastatic Breast Cancer.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 157 (actual)
- Sponsor
- ARCAGY/ GINECO GROUP · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To discover if the adding of a coxib increases the efficacy of the Aromasine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | 2 tablets twice a day per os |
| DRUG | Celecoxib | 2\*200 mg tablets twice a day per os |
| DRUG | Exemestane | Exemestane 25 mg per day per os |
Timeline
- Start date
- 2003-07-01
- Primary completion
- 2004-12-01
- Completion
- 2004-12-01
- First posted
- 2007-09-05
- Last updated
- 2011-06-30
Source: ClinicalTrials.gov record NCT00525096. Inclusion in this directory is not an endorsement.